Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Alvine Pharmaceuticals

Explore full profile

An innovative biopharmaceutical company focused on autoimmune/inflammatory diseases

San Carlos, United StatesFounded 2005Biotech & Life Sciences
Valuation $250–500M Last recorded · 2013
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Alvine Pharmaceuticals and the history behind them.

About Alvine Pharmaceuticals

LLCSwan, established in 2005 by Tina Crawford, is a premier content editing platform dedicated to enhancing the quality of written communication for businesses and individuals. The company operates in the content editing and legal services market, primarily serving small to medium-sized enterprises (SMEs) and individual entrepreneurs. LLCSwan specializes in providing comprehensive editing services that ensure clarity, coherence, and impact in all forms of written content. Additionally, the company offers guidance on forming limited liability companies (LLCs), helping clients navigate the complexities of legal structures and compliance with state and federal regulations.

LLCSwan's business model revolves around a subscription-based service, where clients pay a recurring fee for access to a suite of editing tools and personalized editing services. The company generates revenue through these subscriptions as well as one-time fees for specialized services such as legal document preparation and business incorporation assistance.

Operating in a competitive market, LLCSwan differentiates itself through its commitment to quality, customer satisfaction, and a deep understanding of the legal intricacies involved in business formation. The platform's user-friendly interface and expert editorial team make it a preferred choice for clients seeking reliable and efficient editing solutions.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2005
Headquarters
San Carlos, United States
Open positions
None listed
Dealroom signal
24.0/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
b2b
Links
Website

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCOther financing May 2013 $70M $280M Abbvie Biotech Ventures —
DEBTDebt Jan 2013 $6M — Abbvie Biotech Ventures —
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Alvine Pharmaceuticals website traffic

Latest recorded traffic for Alvine Pharmaceuticals is 730 monthly website visits, up 135.5% over the last three months.

Latest monthly visits730 3-month web change+135.5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

  • Sofinnova Investments
  • Prospect Venture Partners

Series B and later1 investor entered at this stage

  • Abbvie Biotech Ventures
Team profiled 12 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · San Carlos HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Alvine Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Alvine Pharmaceuticals’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.